Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. | 2,722,045 | reported | 09 Mar 2020 | tx 9−13,988 |
| Bolt Biotherapeutics, Inc. | 1,952,302 | reported | 21 Nov 2023 | tx 3−3,400 |
| Nabriva Therapeutics AG | 494,329 | reported | 18 Sept 2017 | tx 2+52,631 |
| THOMPSON DESIGNS INC | 317,270 | reported | 25 Jun 2019 | tx 5+4,328,571−2,625,779 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Nov 2023 | SALE | Bolt Biotherapeutics, Inc. | 236 | 0.90 USD | |
| 21 Nov 2023 | SALE | Bolt Biotherapeutics, Inc. | 1,707 | 0.90 USD | |
| 21 Nov 2023 | SALE | Bolt Biotherapeutics, Inc. | 1,457 | 0.90 USD | |
| 09 Mar 2020 | SALE | Crinetics Pharmaceuticals, Inc. | 347 | 19.50 USD | |
| 09 Mar 2020 | SALE | Crinetics Pharmaceuticals, Inc. | 133 | 19.50 USD | |
| 09 Mar 2020 | SALE | Crinetics Pharmaceuticals, Inc. | 48 | 19.50 USD | |
| 07 Feb 2020 | SALE | Crinetics Pharmaceuticals, Inc. | 1,134 | 22.00 USD | |
| 07 Feb 2020 | SALE | Crinetics Pharmaceuticals, Inc. | 157 | 22.00 USD | |
| 07 Feb 2020 | SALE | Crinetics Pharmaceuticals, Inc. | 4,614 | 22.00 USD | |
| 10 Feb 2020 | SALE | Crinetics Pharmaceuticals, Inc. | 1,451 | 21.40 USD | |
| 10 Feb 2020 | SALE | Crinetics Pharmaceuticals, Inc. | 5,904 | 21.40 USD | |
| 10 Feb 2020 | SALE | Crinetics Pharmaceuticals, Inc. | 200 | 21.40 USD | |
| 25 Jun 2019 | SALE | THOMPSON DESIGNS INC | 327,870 | 1.02 USD | |
| 07 Mar 2018 | SALE | THOMPSON DESIGNS INC | 2,000,000 | 0.36 USD | |
| 30 Jan 2018 | CONVERSION | THOMPSON DESIGNS INC | 4,328,571 | 0.00 USD | |
| 30 Jan 2018 | CONVERSION | THOMPSON DESIGNS INC | 1,515 | 0.00 USD | deriv |
| 09 Nov 2017 | SALE | THOMPSON DESIGNS INC | 296,394 | 0.20 USD | |
| 18 Sept 2017 | PURCHASE | Nabriva Therapeutics AG | 6,386 | 9.46 USD | |
| 18 Sept 2017 | PURCHASE | Nabriva Therapeutics AG | 46,245 | 9.46 USD |